QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
AstraZeneca
Tesaro, Inc.
Memgen, Inc.
NuCana plc
OncoC4, Inc.
Eli Lilly and Company
Dartmouth-Hitchcock Medical Center
Case Comprehensive Cancer Center